In a previous post, we explained how Moderna is leading the race with its cutting-edge mRNA-based vaccine. This post is based on the information currently available through scientific papers, news articles, health news and updates, and existing scientific literature regarding vaccine development. To help you understand the race to a COVID-19 vaccine, Fancy Comma and The Shared Microscope have teamed up to profile promising vaccine candidates that are the frontrunners in this effort. Hundreds of vaccines are in the pipeline worldwide, but which will make it out of clinical trials and help us move past the COVID-19 pandemic? In many states, bars and restaurants have closed dine-in operations to avoid sparking another drastic increase in COVID-19 infections.Ĭlearly, the clock is ticking for a solution to end the pandemic. In the United States, many states are rolling back reopening efforts due to a rise in new COVID-19 cases. With various countries cautiously emerging from lockdown, and social distancing still being enforced by governments, the hunt for a vaccine has never looked so desperate. This post was originally written by Nidhi Parekh for Fancy Comma LLC, and first appeared here.
0 Comments
Leave a Reply. |